Nayan Acharya
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 5%
- Attention Deficit Hyperactivity Disorder
- Bipolar Disorder and Treatment
Papers in
-
- Attention Deficit Hyperactivity Disorder 3
- Schizophrenia research and treatment 2
- Bipolar Disorder and Treatment 2
- Electroconvulsive Therapy Studies 2
- Epilepsy research and treatment 1
-
- Psoriasis: Treatment and Pathogenesis 5
- Co-authors
- Wen Xu (5 shared papers)John Polzer (4 shared papers)Mark E. Bangs (3 shared papers)Sitra Tauscher‐Wisniewski (3 shared papers)Albert J. Allen (2 shared papers)Shuyu Zhang (2 shared papers)Mamitaro Ohtsuki (3 shared papers)Saad Shakir (3 shared papers)
- Journals
- Journal of Clinical Psychopharmacology (2 papers)Journal of the American Academy of Dermatology (2 papers)Pharmacoepidemiology and Drug Safety (1 paper)Psychotherapy and Psychosomatics (1 paper)Expert Opinion on Drug Safety (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Nayan Acharya
21 papers receiving 674 citations
Peers
Comparison fields: 5 of 84
- Biological Psychiatry 51
- Psychiatry and Mental health 195
- Immunology 211
- Dermatology 74
- Behavioral Neuroscience 29
Countries citing papers authored by Nayan Acharya
This map shows the geographic impact of Nayan Acharya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nayan Acharya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nayan Acharya more than expected).
Fields of papers citing papers by Nayan Acharya
This network shows the impact of papers produced by Nayan Acharya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nayan Acharya. The network helps show where Nayan Acharya may publish in the future.
Co-authors
The 25 scholars most cited alongside Nayan Acharya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 98 | |
| 2 | 2016 | 98 | |
| 3 | 2017 | 88 | |
| 4 | 2016 | 72 | |
| 5 | 2006 | 45 | |
| 6 | 2017 | 44 | |
| 7 | 2012 | 38 | |
| 8 | 2006 | 34 | |
| 9 | 2008 | 23 | |
| 10 | 2010 | 20 | |
| 11 | 2006 | 19 | |
| 12 | 2008 | 16 | |
| 13 | 2007 | 16 | |
| 14 | 2001 | 15 | |
| 15 | 2022 | 15 | |
| 16 | 2005 | 14 | |
| 17 | 2012 | 13 | |
| 18 | 2008 | 10 | |
| 19 | 2010 | 8 | |
| 20 | The Psoriatic Disease Payer Advisory Panel. | 2016 | 8 |
About Nayan Acharya
Nayan Acharya is a scholar working on Psychiatry and Mental health, Immunology, Pharmacology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 22 papers that have together received 695 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (5 papers), Attention Deficit Hyperactivity Disorder (3 papers), Schizophrenia research and treatment (2 papers), Bipolar Disorder and Treatment (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Treatment of Major Depression (2 papers), Electroconvulsive Therapy Studies (2 papers) and Epilepsy research and treatment (1 paper). The work is most often cited by research in Biological Psychiatry (51 citations), Psychiatry and Mental health (195 citations), Immunology (211 citations), Dermatology (74 citations) and Behavioral Neuroscience (29 citations). Nayan Acharya has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Wen Xu, John Polzer, Mark E. Bangs, Sitra Tauscher‐Wisniewski, Albert J. Allen, Shuyu Zhang, Mamitaro Ohtsuki, Saad Shakir, Deborah N. D’Souza and Susan Ball. Their work appears in journals such as Journal of Clinical Psychopharmacology, Journal of the American Academy of Dermatology, Pharmacoepidemiology and Drug Safety, Psychotherapy and Psychosomatics and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.